Pyrin Antibody [L17B15]

Catalog No.: F2811

    Application: Reactivity:
    • Lane 1: Bone marrow derived-macrophage of WT C57/B6 mice
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:100
    Application
    WB, IP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    86 kDa 110 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。

    Datasheet & SDS

    生物学的記述

    Specificity
    Pyrin Antibody [L17B15] detects endogenous levels of total Pyrin protein.
    Clone
    L17B15
    Synonym(s)
    MEF, TRIM20, MEFV, Pyrin, Marenostrin
    Background
    Pyrin is an innate immune sensor encoded by the MEFV gene that belongs to the TRIM family and functions as a cytosolic pattern‑recognition receptor assembling an inflammasome in response to defined disturbances in cytoskeletal and Rho GTPase–dependent homeostasis rather than by directly binding microbial ligands. The protein contains an N‑terminal pyrin domain that mediates homotypic interactions with the adaptor ASC, a central B‑box and coiled‑coil region that support higher‑order assembly and association with cytoskeletal and regulatory partners, and a C‑terminal B30.2/SPRY domain implicated in sensing upstream regulatory changes and in conferring allele‑specific effects on activation threshold. Under resting conditions, RhoA GTPases and their downstream kinases PKN1 and PKN2 phosphorylate pyrin at specific serine residues, creating docking sites for 14‑3‑3 proteins that maintain pyrin in an inactive state, so that intact RhoA signaling keeps the pyrin inflammasome off despite the presence of MEFV. Bacterial toxins and effectors that inactivate RhoA or otherwise disrupt its signaling relieve this repression by preventing pyrin phosphorylation and 14‑3‑3 binding, which permits pyrin oligomerization, ASC recruitment via pyrin–PYD to ASC–PYD interactions, and subsequent recruitment and proximity‑induced activation of pro‑caspase‑1. Activated caspase‑1 cleaves pro–IL‑1β and pro–IL‑18 into their mature forms and processes gasdermin D to drive pyroptotic cell death, thereby coupling detection of pathogen‑induced RhoA inactivation to rapid release of key pro‑inflammatory cytokines and lytic elimination of the infected cell. Pyrin is expressed at high levels in neutrophils, monocytes, and macrophages and contributes to host defense against pathogens that target Rho GTPases, with pyrin‑dependent inflammasome activation lowering bacterial loads and shaping inflammatory responses in lung, gut, and systemic infection models. Missense and truncating mutations in MEFV, particularly within the B30.2 domain, lower the activation threshold or disrupt negative regulation of pyrin, resulting in constitutive or exaggerated inflammasome assembly, increased caspase‑1 activity, and excessive IL‑1β/IL‑18 production that underlie familial Mediterranean fever and other pyrin‑associated autoinflammatory diseases.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください